Medication options Flashcards
1
Q
How does Angiotensin II increase BP?
A
- Systemic vasoconstriction
- Aldosterone release - increases Na + H2O reabsorption
2
Q
MOA of ACE-I:
A
- Inhibits ACE
- Reduces angiotensin II production
- Reduces BP
3
Q
MOA ARB:
A
- Blocks angiotensin II from binding to its receptor
- Reduces BP
4
Q
S/E - ACE-I (mainly):
A
- Dry cough
- Angioedema
5
Q
S/E both ACE-I & ARBs:
A
- Hyperkalemia
- Hyponatremia
- Acute renal failure (in patients with severe bilateral renal artery stenosis)
6
Q
CI of ACE-I & ARBs in specific population group:
A
- 2nd & 3rd trimester of pregnancy - fetotoxicity
7
Q
MOA of B-Blockers:
A
- Block action of epinephrine
- By preventing it from binding to the beta-adrenergic receptor
- Reduces HR
- Promotes vasodilation
8
Q
NB uses of B-blockers for HPT pt with other co-morbidities:
A
- IHD
- CCF
9
Q
S/E of B-blockers:
A
- Increased lipid & cholesterol levels
- Worsen of depression Sx
- Bronchospasm - make asthma and COPD worse
- Hyperkalemia
10
Q
MOA of CCB:
A
- Block Ca entry into smooth mm.
- Smooth muscle relaxation
- Vasodilation
- Lowers BP
11
Q
Classes of CCBs:
A
- Dihydropyridines - Amlodipine, Nifedipine
- Non-dihydropyridines - Verapamil
12
Q
Which class of CCBs are most commonly used to treat hypertension because of their strong systemic vasodilatory effect?
A
Dihydropyridines
13
Q
S/E of CCBs:
A
- Flushing
- Dizziness
- Reflex tachycardia
- Constipation
- Edema of the feet
14
Q
All CCBs should be avoided in which patients?
A
- CCF with a reduced ejection fraction
15
Q
Non-dihydropyridine CCBs should not be routinely combined with:
A
- Beta-blockers
- Because of the risk of bradycardia & heart block